Logo image of ENSV

ENSERVCO CORP (ENSV) Stock Fundamental Analysis

NYSEARCA:ENSV - NYSE Arca - US29358Y2019 - Common Stock - Currency: USD

0.1452  +0 (+0.14%)

Fundamental Rating

1

Overall ENSV gets a fundamental rating of 1 out of 10. We evaluated ENSV against 62 industry peers in the Energy Equipment & Services industry. Both the profitability and financial health of ENSV have multiple concerns. ENSV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ENSV had negative earnings in the past year.
ENSV had a positive operating cash flow in the past year.
ENSV had negative earnings in each of the past 5 years.
ENSV had negative operating cash flow in 4 of the past 5 years.
ENSV Yearly Net Income VS EBIT VS OCF VS FCFENSV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M

1.2 Ratios

ENSV has a Return On Assets of -56.39%. This is amonst the worse of the industry: ENSV underperforms 98.36% of its industry peers.
ENSV has a worse Return On Equity (-437.54%) than 93.44% of its industry peers.
Industry RankSector Rank
ROA -56.39%
ROE -437.54%
ROIC N/A
ROA(3y)-40.51%
ROA(5y)-29.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ENSV Yearly ROA, ROE, ROICENSV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K

1.3 Margins

With a Gross Margin value of 17.70%, ENSV is not doing good in the industry: 73.77% of the companies in the same industry are doing better.
ENSV's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ENSV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-13.75%
ENSV Yearly Profit, Operating, Gross MarginsENSV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

More info and screens

0

2. Health

2.1 Basic Checks

ENSV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ENSV has been increased compared to 1 year ago.
Compared to 5 years ago, ENSV has more shares outstanding
ENSV has a worse debt/assets ratio than last year.
ENSV Yearly Shares OutstandingENSV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
ENSV Yearly Total Debt VS Total AssetsENSV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

ENSV has an Altman-Z score of -4.73. This is a bad value and indicates that ENSV is not financially healthy and even has some risk of bankruptcy.
ENSV has a Altman-Z score of -4.73. This is amonst the worse of the industry: ENSV underperforms 90.16% of its industry peers.
The Debt to FCF ratio of ENSV is 17.31, which is on the high side as it means it would take ENSV, 17.31 years of fcf income to pay off all of its debts.
ENSV's Debt to FCF ratio of 17.31 is on the low side compared to the rest of the industry. ENSV is outperformed by 62.30% of its industry peers.
A Debt/Equity ratio of 1.08 is on the high side and indicates that ENSV has dependencies on debt financing.
ENSV's Debt to Equity ratio of 1.08 is on the low side compared to the rest of the industry. ENSV is outperformed by 80.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 17.31
Altman-Z -4.73
ROIC/WACCN/A
WACC12.29%
ENSV Yearly LT Debt VS Equity VS FCFENSV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

ENSV has a Current Ratio of 0.99. This is a bad value and indicates that ENSV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.99, ENSV is not doing good in the industry: 95.08% of the companies in the same industry are doing better.
ENSV has a Quick Ratio of 0.99. This is a bad value and indicates that ENSV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.96, ENSV is not doing good in the industry: 80.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.96
ENSV Yearly Current Assets VS Current LiabilitesENSV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.36% over the past year.
The Revenue has been growing slightly by 3.26% in the past year.
ENSV shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.40% yearly.
EPS 1Y (TTM)58.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)3.26%
Revenue growth 3Y12.05%
Revenue growth 5Y-12.4%
Sales Q2Q%0.94%

3.2 Future

The Earnings Per Share is expected to grow by 35.37% on average over the next years. This is a very strong growth
Based on estimates for the next years, ENSV will show a very strong growth in Revenue. The Revenue will grow by 25.68% on average per year.
EPS Next Y64.92%
EPS Next 2Y35.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year33.02%
Revenue Next 2Y25.68%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ENSV Yearly Revenue VS EstimatesENSV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ENSV Yearly EPS VS EstimatesENSV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2023 2024 2025 0 1 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ENSV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ENSV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ENSV Price Earnings VS Forward Price EarningsENSV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as ENSV.
Industry RankSector Rank
P/FCF 24.56
EV/EBITDA N/A
ENSV Per share dataENSV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

ENSV's earnings are expected to grow with 35.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.37%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ENSV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENSERVCO CORP

NYSEARCA:ENSV (11/1/2024, 8:04:00 PM)

0.1452

+0 (+0.14%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)08-14 2024-08-14/amc
Earnings (Next)11-13 2024-11-13/amc
Inst Owners3.78%
Inst Owner Change-76.46%
Ins Owners56.46%
Ins Owner Change0%
Market Cap6.66M
Analysts82.5
Price Target5.1 (3412.4%)
Short Float %0.14%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend11.04
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)143.88%
Min EPS beat(2)14.75%
Max EPS beat(2)273.01%
EPS beat(4)2
Avg EPS beat(4)54.65%
Min EPS beat(4)-50.06%
Max EPS beat(4)273.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.75%
Min Revenue beat(2)-4%
Max Revenue beat(2)2.51%
Revenue beat(4)1
Avg Revenue beat(4)-5.13%
Min Revenue beat(4)-15.31%
Max Revenue beat(4)2.51%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.29
P/FCF 24.56
P/OCF 10.35
P/B 4.45
P/tB 4.74
EV/EBITDA N/A
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)0.01
FCFY4.07%
OCF(TTM)0.01
OCFY9.66%
SpS0.5
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -56.39%
ROE -437.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.7%
FCFM 1.18%
ROA(3y)-40.51%
ROA(5y)-29.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-13.75%
F-Score6
Asset Turnover1.98
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 17.31
Debt/EBITDA N/A
Cap/Depr 13.33%
Cap/Sales 1.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.96
Altman-Z -4.73
F-Score6
WACC12.29%
ROIC/WACCN/A
Cap/Depr(3y)7.9%
Cap/Depr(5y)10.29%
Cap/Sales(3y)2.03%
Cap/Sales(5y)2.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y64.92%
EPS Next 2Y35.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.26%
Revenue growth 3Y12.05%
Revenue growth 5Y-12.4%
Sales Q2Q%0.94%
Revenue Next Year33.02%
Revenue Next 2Y25.68%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year127.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y113.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y146.26%
OCF growth 3YN/A
OCF growth 5YN/A